Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

APLT Applied Therapeutics Inc

4,76

0,23 (5,08%)

04 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Applied Therapeutics (NASDAQ:APLT)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Applied Therapeutics Charts.

Applied Therapeutics (NASDAQ:APLT)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Applied Therapeutics Charts.

News Applied Therapeutics Inc

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
Montag 15 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
Donnerstag 4 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
Donnerstag 28 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
Mittwoch 6 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Applied Therapeutics Announces $100 Million Private Placement
Mittwoch 28 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
Mittwoch 28 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Applied Therapeutics Inc News-Artikel

Invesco QQQ Trust Series 1

Euro vs US Dollar

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen